Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$84.3 - $94.31 $59,768 - $66,865
709 Added 9.11%
8,493 $784,000
Q1 2024

Apr 11, 2024

BUY
$72.54 - $95.56 $37,793 - $49,786
521 Added 7.17%
7,784 $743,000
Q4 2023

Jan 25, 2024

BUY
$61.71 - $77.76 $448,199 - $564,770
7,263 New
7,263 $553,000
Q2 2023

Aug 03, 2023

SELL
$81.41 - $94.33 $6,757 - $7,829
-83 Reduced 1.51%
5,425 $511,000
Q1 2023

May 09, 2023

BUY
$74.26 - $84.51 $8,094 - $9,211
109 Added 2.02%
5,508 $455,000
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $17,689 - $22,646
259 Added 5.04%
5,399 $402,000
Q3 2022

Nov 10, 2022

BUY
$82.37 - $107.29 $14,085 - $18,346
171 Added 3.44%
5,140 $358,000
Q2 2022

Aug 09, 2022

BUY
$86.5 - $128.27 $22,057 - $32,708
255 Added 5.41%
4,969 $527,000
Q1 2022

May 11, 2022

BUY
$101.96 - $128.34 $30,282 - $38,116
297 Added 6.72%
4,714 $555,000
Q4 2021

Feb 02, 2022

BUY
$106.37 - $130.68 $14,679 - $18,033
138 Added 3.23%
4,417 $572,000
Q3 2021

Oct 19, 2021

SELL
$102.91 - $122.75 $16,053 - $19,149
-156 Reduced 3.52%
4,279 $484,000
Q2 2021

Jul 29, 2021

SELL
$83.84 - $104.76 $4,778 - $5,971
-57 Reduced 1.27%
4,435 $459,000
Q1 2021

Apr 19, 2021

BUY
$78.68 - $90.67 $19,197 - $22,123
244 Added 5.74%
4,492 $376,000
Q4 2020

Feb 02, 2021

BUY
$71.69 - $91.23 $40,648 - $51,727
567 Added 15.4%
4,248 $385,000
Q3 2020

Oct 13, 2020

BUY
$67.19 - $87.44 $22,307 - $29,030
332 Added 9.91%
3,681 $294,000
Q2 2020

Aug 03, 2020

BUY
$57.54 - $76.95 $192,701 - $257,705
3,349 New
3,349 $231,000
Q1 2020

Apr 17, 2020

SELL
$52.41 - $81.0 $52,986 - $81,891
-1,011 Closed
0 $0
Q4 2019

Jan 22, 2020

BUY
$71.7 - $82.09 $72,488 - $82,992
1,011 New
1,011 $236,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Rfg Advisory, LLC Portfolio

Follow Rfg Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rfg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rfg Advisory, LLC with notifications on news.